Stocks · Health care · Biological Products, (No Diagnostic Substances)

PRECISION BIOSCIENCES INC

DTIL Clue Score48
United States Fiscal year ends May CIK 0001357874 Results filed 3 Nov 2026

What the insiders did Net buying

By person

9 insiders · 14 transactions
2.2×

Michael Amoroso holds only 2.2 times base salary in stock. $1.46M of shares against $650.88K in salary for 2025.

Salary from the company's own proxy. The shares are what Michael Amoroso last reported holding, valued at $6.00, the price Common Stock was last bought or sold at on the open market here, on 28 Sep 2026.

Insider
Role
Bought
Sold
Net
Holding
Worth
Change
Michael Amoroso
President and CEO
—
$224.06K (2) scheduled
−$224.06K
243,392
$1.46M
+752.9%
John Alexander Kelly
Chief Financial Officer
—
$92.60K (2) scheduled
−$92.60K
125,883
$755.30K
+225.8%
J. Jefferson Smith
Chief Research Officer
—
$60.02K (2) scheduled
−$60.02K
121,926
$731.56K
+69.4%
Dario Scimeca
General Counsel and Secretary
—
$54.59K (2) scheduled
−$54.59K
56,457
$338.74K
+461.4%
Geno J Germano
Director
$30.54K (2)
—
+$30.54K
47,492
$284.95K
+1,030%
Stanley Frankel
Director
$18.69K (2)
—
+$18.69K
41,478
$248.87K
+875.5%
Melinda Brown
Director
$13.98K (2)
—
+$13.98K
45,481
$272.89K
+982.4%
Kevin Buehler
Director
—
—
—
49,137
$294.82K
+1,019%
Shari Lisa Pire
Director
—
—
—
35,028
$210.17K
+733.6%

No percentages here. This company's share count has moved by a factor of 2.6 over the window, from 10,481,931 to 27,601,554 shares. A split, a merger or a large issue changes what the company is, and a holding measured at one point in that run is not a fraction of it at another.